Scalp Microbiome Alterations in Androgenetic Alopecia: Patterns and Emerging Mechanistic Insights.
Study Design
- Loại nghiên cứu
- Review
- Đối tượng nghiên cứu
- patients with androgenetic alopecia
- Can thiệp
- Scalp Microbiome Alterations in Androgenetic Alopecia: Patterns and Emerging Mechanistic Insights. None
- Đối chứng
- None
- Kết quả chính
- scalp microbiome alterations in androgenetic alopecia
- Xu hướng hiệu quả
- Negative
- Nguy cơ sai lệch
- Unclear
Abstract
Androgenetic alopecia (AGA), the most common cause of hair loss in men and women, involves progressive follicular miniaturization and reduced hair density. Emerging evidence implicates the scalp microbiome as a potential modifier of this process. Preliminary evidence suggests alterations in microbial communities in patients with AGA compared to the general population, with the most robust finding being an enrichment of Cutibacterium acnes, particularly in males. Increases in Malassezia and reductions in Lawsonella and Corynebacterium have also been described, though results are less consistent across studies, while Staphylococcus displays variable patterns. These microbial shifts parallel alterations in scalp sebum composition, such as elevated triglycerides and palmitic acid, that may favor growth of lipophilic microbes. Mechanistic insights from in vitro studies and related inflammatory skin conditions indicate that C. acnes and Malassezia spp. are capable of generating free fatty acids and activating innate immune pathways, such as TLR2- and NLRP3-associated signaling, leading to pro-inflammatory cytokine production, potentially contributing to follicular stem cell apoptosis and hair follicle miniaturization. Although findings remain heterogenous, emerging evidence suggests microbial-lipid-immune interactions may contribute to AGA pathogenesis, providing a rationale for exploring treatments like ketoconazole or other lipid-modulating interventions.
Tóm lược
Emerging evidence suggests microbial-lipid-immune interactions may contribute to AGA pathogenesis, providing a rationale for exploring treatments like ketoconazole or other lipid-modulating interventions.
Used In Evidence Reviews
Similar Papers
Skin therapy letter · 2012
Promising therapies for treating and/or preventing androgenic alopecia.
The Journal of dermatology · 2002
Comparative efficacy of various treatment regimens for androgenetic alopecia in men.
The Journal of dermatological treatment · 2019
Topical ketoconazole: a systematic review of current dermatological applications and future developments.
The Journal of dermatology · 2018
Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version.
International journal of cosmetic science · 2002
Nudging hair shedding by antidandruff shampoos. A comparison of 1% ketoconazole, 1% piroctone olamine and 1% zinc pyrithione formulations.
Journal of dermatological science · 2007